|
Wednesday, November 20, 2019
Print Current Day:
 |
|
| SESSION 23 SCHEDULE | |
|
Wednesday
SESSION 23:
GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE LESIONS
Location: Grand Ballroom East, 3rd Floor
Moderators:Enrico Ascher, MD / Craig M. Walker, MD / Frank J. Veith, MD |
|
| x | |
| 6:40 AM - 6:45 AM | Understanding US FDA IDEs (Investigative Device Exemptions) Trials For Evaluating Lower Extremity Endo Devices – Especially BTK Devices: What These Will Tell Us (About Patency) And What They Won’t Tell Us (About Amputation Free Survival) |
|
Presenter(s):Patrick J. Geraghty, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | Optimal Techniques For Vessel Preparation Before Deployment Of A Drug Coated Or Uncoated Balloon Or Stent |
|
Presenter(s):Erwin Blessing, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | Value Of IVUS In Lower Extremity Endovascular Treatments: It Is A Management-Altering, Must Have Game Changer |
|
Presenter(s):Fabrizio Fanelli, MD, EBIR Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | Which Wires And Catheters Are Best To Reach Infrainguinal Arteries Via A Radial Approach: Innovative New Wire Engineering Designs To Improve Performance Of 104 Wires: What Is A Twist Wire And How Does It Work |
|
Presenter(s):Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | Endovascular Treatment Is Appropriate For CLTI Patients With Heel Gangrene Involving The Os Calcis And Achilles Tendon: Limb Salvage With Function Can Be Achieved And How |
|
Presenter(s):Iris Baumgartner, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | What Is The Future Of Stenting In The Current DCB World: DCBs Do Not Always Work For Complex Lesions: Leave Nothing Behind Is Only A Dream |
|
Presenter(s):Marc Bosiers, MD / Koen R. Deloose, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| SOME COMMENTS ON ENDOVASCULAR TREATMENTS OF ARTERIAL LESIONS IN THE FOOT | |
| 7:16 AM - 7:21 AM | How Durable Is The Patency Of Balloon Angioplasty Of Foot Arteries And Plantar Loop Procedures: Why It May Not Matter |
|
Presenter(s):Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:22 AM - 7:27 AM | Should We Treat Foot Vessel Lesions Or Is Such Treatment Fanciful Or Harmful: How Should We Monitor Such Treatment: What Is The End Point And When Is Open Surgery Better |
|
Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | Small Artery Disease (SAD) And Medial Artery Calcification (MAC) In The Foot: What Is Its Role In Severe CLTI And How Is It Best Treated |
|
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:34 AM - 7:39 AM | Open Bypass To Foot Arteries Can Save Limbs If Foot Arteries And Arches Have Not Been Instrumented: A Note Of Caution |
|
Presenter(s):Francesco Spinelli, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:40 AM - 7:45 AM | Role Of Distal Bypass In CLTI With Severe Gangrene: What % Of Such Patients Will Need One At Some Time In Their Course: When Are Pedal Bypasses Better Than Pedal Loop Procedures |
|
Presenter(s):Richard F. Neville, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:46 AM - 7:52 AM | Panel Discussion |
| END OF SESSION 23 | |
| SESSION 24 SCHEDULE | |
|
Wednesday
SESSION 24:
PROGRESS IN STENT BASED TREATMENTS, ATHERECTOMY AND LITHOPLASTY (LITHOTRIPSY) FOR LOWER EXTREMITY OCCLUSIVE LESIONS
Location: Grand Ballroom East, 3rd Floor
Moderators:Patrick J. Geraghty, MD / Kenneth Rosenfield, MD |
|
| x | |
| 7:52 AM - 7:57 AM | DCBs Versus DESs: Advantages And Disadvantages Of Each: Why DCBs Should Be First Line Therapy For Most Lesions In Most Patients |
|
Presenter(s):Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 7:58 AM - 8:03 AM | For Fempop Lesions, Zilver PTX DESs Are Durable Effective Treatment: 5-Year Results Show It Even In Adverse Circumstances: New Findings From The Zilver PTX RCT |
|
Presenter(s):Michael D. Dake, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:04 AM - 8:09 AM | Which Patients With Fempop Occlusive Lesions Are Not Candidates For DCB Treatment: How Should They Be Treated |
|
Presenter(s):Fabrizio Fanelli, MD, EBIR Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:10 AM - 8:15 AM | New Findings From The IMPERIAL RCT Comparing Zilver PTX DESs With Eluvia DESs For Fempop Lesions: Do Differences In Technology And Results In High Risk Subgroups Suggest That Eluvia Is A Better Stent |
|
Presenter(s):William A. Gray, MD / Stefan Mueller-Huelsbeck, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:16 AM - 8:21 AM | Not Sure That IMPERIAL RCT To Date Shows Differences That Are Important: Zilver PTX Is Still A Good DES With Favorable Longer-Term Results And Both Stents Produced Equal Improvement In Symptoms |
|
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:22 AM - 8:27 AM | Another View On When To Use Which Stent For Fempop Lesions: Supera, Zilver PTX, Eluvia Or Others |
|
Presenter(s):Iris Baumgartner, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:28 AM - 8:33 AM | Eluvia (Boston Scientific) Is The Only Polymer Based Paclitaxel DES Technology, And It Is Now Being Studied For BTK Lesions In The SAVAL RCT |
|
Presenter(s):Patrick J. Geraghty, MD / Jihad A. Mustapha, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:34 AM - 8:39 AM | Bioresorbable Everolimus DESs For Treating BTK Lesions: The Results With The Absorb Stent (Abbott) Were Favorable For 5 Years: What Does The Future Hold For Such Stents |
|
Presenter(s):Steven Kum, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:40 AM - 8:45 AM | Current Status And Improvements In Atherectomy Devices: Which One Or Ones Are Best And Why: For Stand-Alone Treatment Or For Vessel Preparation For Other Treatments |
|
Presenter(s):Lawrence A. Garcia, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:46 AM - 8:51 AM | Which Atherectomy Device Is Best And Why; A European Perspective And Shockwave Based Technology With A Jack-Hammer Effect To Facilitate CTO Wire Crossing (From Soundbite Medical Solutions); How It Works |
|
Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:52 AM - 8:57 AM | Update On Intravascular Lithotripsy (Lithoplasty) To Treat Calcified Occlusive Lesions: When Is It Worthwhile And When Not: From The DISRUPT PAD Trials And The REAL World Registry |
|
Presenter(s):Andrew Holden, MBChB Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 8:58 AM - 9:02 AM | Late Breaking 5-Year Results Of Bioresorbable DES (Abbott) For BTK Lesions: Future Implications |
|
Presenter(s):Brian G. DeRubertis, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:02 AM - 9:10 AM | Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 24 | |
| SESSION 25 SCHEDULE | |
|
Wednesday
SESSION 25:
NEW DEVELOPMENTS IN LOWER EXTREMITY RELATED TOPICS: DOWNSIDE OF DCBs: THE PACLITAXEL COATED DEVICES INCREASE MORTALITY ISSUE
|
|
| x | |
| 9:10 AM - 9:15 AM | Introductory Remarks And Overview |
|
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:16 AM - 9:21 AM | The Downsides To DCBs: Cost; Distal Embolization; Increased Mortality: Are They Substantive |
|
Presenter(s):Andrew Holden, MBChB Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:22 AM - 9:27 AM | Update On The Meta-Analysis Showing An Increased Mortality In Patients Treated With Drug (Paclitaxel) Coated Lower Extremity Devices (DCBs And DESs): What Is The Current Interpretation |
|
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:28 AM - 9:33 AM | Understanding The Pharmacology, Mechanisms Of Action And Toxicity Of Paclitaxel On Drug Coated Devices: How Could Paclitaxel Influence Mortality |
|
Presenter(s):Juan F. Granada, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:34 AM - 9:39 AM | Is The Increased Mortality Risk Of Paclitaxel Coated Lower Extremity Devices Observed In The Meta-Analysis Real And Meaningful: Update From The VIVA Leaders Analysis: Currently How Should It Influence Use Of These Devices: Where Is This Issue Going |
|
Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:40 AM - 9:45 AM | Current Status Of The Discussion On Paclitaxel Coated Lower Extremity Devices And Their Impact On Patient Mortality: Another View And Where Does The FDA Stand And Why |
|
Presenter(s):Michael R. Jaff, DO Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:46 AM - 9:51 AM | What Is The Society for Vascular Surgery (SVS) Doing About This Issue And Where Does It Stand On It |
|
Presenter(s):Kim J. Hodgson, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:52 AM - 9:57 AM | What Is The Response To And Position Of An Industry Partner (Medtronic) Which Is Vested In Drug Eluting Technology |
|
Presenter(s):Mark Pacyna Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 9:58 AM - 10:03 AM | Update On The Late Results (> 5 Years) Of The Zilver PTX DES Trials That Are Relevant To This Issue: Including The Corrected Late Patient Mortality Data |
|
Presenter(s):Michael D. Dake, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:04 AM - 10:09 AM | Long-Term Safety And Effectiveness Of Paclitaxel Coated Devices Versus Non-Coated Devices For Fempop Occlusive Lesions: From Japanese RCTs And Registries: How Do These Data Bear On The Paclitaxel-Mortality Issue |
|
Presenter(s):Osamu Iida, MD / Hiroyoshi Yokoi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:10 AM - 10:15 AM | 6-Year Comparison Of Mortality And Its Causes In 1500 Patients Treated With Paclitaxel Coated DCBs Or DESs Versus Bare Metal Stents (BMSs) Or Plain Old Balloon Angioplasty (POBA) |
|
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:16 AM - 10:19 AM | Large Population Based Multicenter German Study Indicates Paclitaxel Coated Devices May Be Associated With Lower Late Mortality Than Uncoated Devices In Some Patient Subgroups |
|
Presenter(s):Christian A. Behrendt, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:19 AM - 10:25 AM | Panel Discussion |
| END OF SESSION 25 | |
| SESSION 26 SCHEDULE | |
|
Wednesday
SESSION 26:
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND OTHER DEVICES FOR TREATING LOWER EXTREMITY OCCLUSIVE LESIONS; RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK TREATMENTS (5- AND 4-MINUTE SHORT SUMMARY [SS] TALKS)
|
|
| x | |
| 10:25 AM - 10:30 AM | Present Status And Future Potential Of DCBs: Is Durability Maintained: Preventing Restenosis And Catch-Up: Importance Of Dual Antiplatelet Agents |
|
Presenter(s):Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:31 AM - 10:36 AM | Best Current Treatment For Long Complex Lesions Is DCBs With Provisional Stenting: What Is The Evidence |
|
Presenter(s):John R. Laird, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:37 AM - 10:42 AM | The REAL PTX RCT Compares DESs Versus DCBs For Treating Fempop Lesions, Some Long And Complex: At 2 Years, Results Are Better With DESs |
|
Presenter(s):Andrej Schmidt, MD / Yvonne Bausback, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:43 AM - 10:48 AM | 5-Year Results From The IN.PACT SFA RCTs Shows Maintained Benefit Of In.Pact DCB Versus POBA For Treatment Of SFA Lesions With No Increase In Complications Or Mortality |
|
Presenter(s):Peter A. Schneider, MD / John R. Laird, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:49 AM - 10:54 AM | The Real World GLOBAL REGISTRY Confirms The Value Of The In.Pact DCB For Treating More Complex SFA Lesions Including In Stent Restenosis (ISR) |
|
Presenter(s):Marianne Brodmann, MD / Gary M. Ansel, MD / Jos C. van den Berg, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:55 AM - 11:00 AM | 2-Year Results Of The COMPARE PILOT RCT Comparing The Ranger DCB (Boston Scientific) With The In.Pact DCB (Medtronic) For Treating Complex Fempop Lesions And 12-Month Results Of Ranger II Trial |
|
Presenter(s):Dierk Scheinert, MD / Thomas Zeller, MD / Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:01 AM - 11:06 AM | Safety And Effectiveness Of The Stellarex DCB (Philips) With Low Dose Paclitaxel Up To 3 Years In The Treatment Of Fempop Occlusive Lesions |
|
Presenter(s):Fabrizio Fanelli, MD, EBIR / Sean P. Lyden, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:07 AM - 11:12 AM | Panel Discussion |
| BELOW THE KNEE DCBs | |
| 11:13 AM - 11:18 AM | The ACO ART II RCT Shows Favorable Results With The Orchid DCB To Treat BTK Lesions: With The Right DCB Technology The Future For BTK DCBs Is Brighter Than The Past |
|
Presenter(s):Francesco Liistro, MD / Wei Guo, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:19 AM - 11:24 AM | Results Of A RCT Show The Lutonix DCB (Becton Dickinson/Bard) To Be Better Than POBA For BTK Occlusive Lesions |
|
Presenter(s):Patrick J. Geraghty, MD / Jihad A. Mustapha, MD / Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:25 AM - 11:30 AM | Value Of The Stellarex DCB (Philips) For Treating BTK Occlusive Lesions: The ILLUMINATE BTK Trial |
|
Presenter(s):Craig M. Walker, MD / Mahmood Razavi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:31 AM - 11:36 AM | Update On SurVeil DCBs (Surmodics/Abbott) For Treating BTK Lesions: What Makes This DCB Different: 1-Year Safety And Efficacy From The PreVail Trial |
|
Presenter(s):Kenneth Rosenfield, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:37 AM - 11:42 AM | Economic Factors In The Treatment Of CLTI: Are Drug Coated Balloons (DCBs) DESs Stents Cost Effective: How Can The Costs Of Devices Be Met |
|
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:43 AM - 11:48 AM | What Is The Importance Of Dual Antiplatelet Agents To The Success Of DCBs And What Is The Current Status Of DCBs With Drugs Other Than Paclitaxel |
|
Presenter(s):Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| SHORT SUMMARY 4-MINUTE TALKS | |
| 11:49 AM - 11:53 AM | [SS] Value Of A Scoring Balloon (Ultrascore From Becton Dickinson/Bard) In Vessel Preparation Before DCB Use In Fempop Lesions: How It Works And Experience To Date |
|
Presenter(s):Marcus Thieme, MD / Dierk Scheinert, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:53 AM - 11:57 AM | [SS] DEBATE: SFA Endovascular Treatment Durability Does Not Require Drug Eluting Devices: The Evidence |
|
Presenter(s):Lawrence A. Garcia, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:57 AM - 12:01 PM | [SS] DEBATE: Not So: Drug Elution Is Essential For SFA Endovascular Treatments To Be Effective And Durable |
|
Presenter(s):Thomas Zeller, MD / Andrej Schmidt, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 12:01 PM - 12:06 PM | Panel Discussion |
| 12:06 PM - 1:00 PM | Lunch Break – 2nd Floor PromenadeVisit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 26 | |
| SESSION 27 SCHEDULE | |
|
Wednesday
SESSION 27:
EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY OCCLUSIVE DISEASE CAUSING SEVERE CHRONIC LIMB THREATENING ISCHEMIA (CLTI): HOW TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT” WITH NO PATENT TARGET ARTERIES
Location: Grand Ballroom East, 3rd Floor
Moderators:Daniel G. Clair, MD / Giancarlo Biamino, MD, PhD / Frank J. Veith, MD |
|
| x | |
| 1:00 PM - 1:05 PM | How To Gain Retrograde Arterial Access Via Leg Arteries: The Tibioperoneal Trunk, Peroneal, Posterior Tibial And Anterior Tibial: Equipment And Technical Tips |
|
Presenter(s):Miguel F. Montero-Baker, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | ‘Fancy’ Techniques For Getting A Guidewire Across Difficult Chronic Total Occlusions – Especially Those In BTK Arteries In CLTI Patients |
|
Presenter(s):Osamu Iida, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | No Option CLTI: The “Desert Foot”: An Increasing Epidemic: An Overview Of Solutions For It And How To Salvage Some Of These Limbs |
|
Presenter(s):Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Extreme Distal Lower Limb Revascularization: Durable Solution Or Technical Show Off: Distal Access, Plantar Loop Procedures And Subintimal Angioplasty In Foot Arteries: What Is Their Impact On Mid And Long-Term Results |
|
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR / Michel Rossi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Treatment Possibilities For “No Option” Patients: Including The Pros And Cons Of Venous Arterialization |
|
Presenter(s):Erwin Blessing, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| UPDATE ON VENOUS ARTERIALIZATION | |
| 1:30 PM - 1:35 PM | Surgical Arterialization Of Foot Veins For No Option CLTI: How To Do It And Long-Term Outcomes: From A Pioneer |
|
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Arterialization Of Foot Veins Can Save Limbs With No Option CLTI: How And Why Does It Work And Why Does It Fail: What Is Hybrid Arterialization Of Foot Veins: How Does It Compare To The LimFlow Totally Endo Procedure |
|
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | Update On Percutaneous Deep Vein Arterialization (pDVA) With The LimFlow Device For No Option CLTI: Techniques And Results |
|
Presenter(s):Steven Kum, MD / Daniel G. Clair, MD / Jihad A. Mustapha, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Panel Discussion |
| 1:53 PM - 1:58 PM | Tibial Bypasses With PTFE Grafts Are Worthwhile (When Autologous Vein Is Lacking) In Hopelessly Threatened Limbs And Can Save A Functional Limb For Many Years: They Deserve A Better Reputation Than They Have |
|
Presenter(s):Gregg S. Landis, MD / Richard F. Neville, MD / Neal S. Cayne, MD / Evan C. Lipsitz, MD, MBA / Nicholas J. Gargiulo III, MD, RPVI, RVT, RDMS, FACS / Frank J. Veith, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 1:59 PM - 2:04 PM | Ultradistal Bypasses To Below The Ankle Arteries Can Save Limbs With CLTI And Gangrene: How Distal In The Foot Can One Go: No Option CLTI Is Usually A Misnomer |
|
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:05 PM - 2:10 PM | Extended Open Techniques To Save Threatened Feet When All Endovascular Attempts Have Failed |
|
Presenter(s):Enrico Ascher, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:11 PM - 2:16 PM | Below The Ankle Angioplasty And Stenting For CLTI: Technical Tips, Indications And Challenges: Poor Patency Rates May Not Hamper Limb Salvage |
|
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:17 PM - 2:22 PM | Panel Discussion |
| END OF SESSION 27 | |
| SESSION 28 SCHEDULE | |
|
Wednesday
SESSION 28:
NEW DEVELOPMENTS IN LOWER EXTREMITY IN STENT RESTENOSIS (ISR); SELF-EXPANDING STENT-GRAFTS (VIABAHN); HEPARIN BONDING; ARTERIAL CALCIFICATION; UNUSUAL LOWER EXTREMITY STENTS AND THE IMPORTANCE OF HEPARIN BONDING TO PTFE GRAFTS AND DCB INFLATION PRESSURES (SEE ALSO SESSION 59)
|
|
| x | |
| IN STENT RESTENOSIS (ISR) | |
| 2:22 PM - 2:27 PM | Update On Best Current Treatment For In Stent Restenosis (ISR): A European Perspective |
|
Presenter(s):Jos C. van den Berg, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:28 PM - 2:33 PM | Update On The Best Current Treatment For ISR Of Varying Grades: A US Perspective |
|
Presenter(s):Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:34 PM - 2:39 PM | A Different View Of Optimal Treatment For Varying Grades Of ISR: When Is A Stent-Graft The Best Treatment |
|
Presenter(s):Marc Bosiers, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| NEW DEVELOPMENTS IN VALUE OF SELF-EXPANDING STENT GRAFTS (VIABAHN) | |
| 2:40 PM - 2:45 PM | Update On Value And Indications Of The Viabahn Self-Expanding Stent-Graft For Fempop Occlusive Disease: Evolution Of The Device: Technical Tips And 5-Year Results From Japan |
|
Presenter(s):Osamu Iida, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:46 PM - 2:51 PM | Value Of Viabahn Stent-Grafts To Treat Failing And Failed Fempop Grafts: Technical Tips And Results |
|
Presenter(s):Naoki Fujimura, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:52 PM - 2:57 PM | Comparison Of Endoluminal Bypass With Viabahn Stent-Grafts Versus Supera Vasculomimetic Stents For Treating Fempop Occlusive Lesions: Indications For And Advantages And Limitations Of Each: When Is An Open Bypass Necessary |
|
Presenter(s):Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 2:58 PM - 3:03 PM | Panel Discussion |
| PTFE-HEPARIN BONDING | |
| 3:03 PM - 3:08 PM | Comparison Of Heparin Bonded PTFE Grafts To Those Without Heparin Bonding |
|
Presenter(s):Yann Gouëffic, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| THE DETOUR PROCEDURE | |
| 3:09 PM - 3:14 PM | Percutaneous (PQ) Transvenous Endovascular Fempop Arterial Bypass For Treating Long (30-40 cm) SFA Occlusions: How Does It Work And 2-Year Results: From The DETOUR Trials |
|
Presenter(s):Sean P. Lyden, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:15 PM - 3:20 PM | Will The Detour Procedure For PQ Endovenous Fempop Arterial Bypass Eliminate The Need For Open Surgery: When Will It And When Won’t It |
|
Presenter(s):Dainis K. Krievins, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| ARTERIAL CALCIFICATION | |
| 3:21 PM - 3:26 PM | Types Of Arterial Calcification And How They Impede Balloon Angioplasty Of Occluded Tibial Arteries: How Can It Be Overcome: The DEKIAP (Direct Extravascular Kalcium Interruption Arterial Procedure): Technique And Results |
|
Presenter(s):Steven Kum, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| UNUSUAL LOWER EXTREMITY STENTS | |
| 3:27 PM - 3:32 PM | Initial Experience With A 3 French Compatible Microstent For Antegrade Or Retrograde Treatment Of Tibial Artery Lesions (From Micro Medical Solutions) |
|
Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:33 PM - 3:38 PM | 2-Year Results With The 3D Helical Stent That Induces Swirling Flow: The MIMICS-2 Trial Shows This Stent Works Well For Complex SFA Lesions (From Veryan Medical) |
|
Presenter(s):Timothy M. Sullivan, MD / Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 3:39 PM - 3:50 PM | Panel Discussion |
| 3:50 PM - 4:00 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 28 | |
| SESSION 29 SCHEDULE | |
|
Wednesday
SESSION 29:
UPDATES ON LOWER EXTREMITY CLTI GUIDELINES, RCTs AND FOOT PERFUSION INDICATORS
|
|
| x | |
| 4:00 PM - 4:10 PM | What Is New And Good About The Recent Multispecialty Global Vascular Guidelines For CLTI: What Are Their Limitations And Why Is TASC Outdated |
|
Presenter(s):Michael S. Conte, MD / Andrew W. Bradbury, MD, FRCSEd / Philippe Kolh, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:11 PM - 4:16 PM | Update On The BASIL 2 And 3 RCTs: 2 Compares Crural Vein Bypasses With Endovascular Treatments; 3 Compares DCBs And DESs With POBA And Uncoated Stents |
|
Presenter(s):Andrew W. Bradbury, MD, FRCSEd Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:17 PM - 4:22 PM | DEBATE: Progress In The BEST-CLI RCT Comparing Open And Endo Treatments: This Trial Will Provide Important New Information On The Best Treatment For CLTI |
|
Presenter(s):Alik Farber, MD / Matthew T. Menard, MD / Kenneth Rosenfield, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:23 PM - 4:28 PM | DEBATE: Sorry, BEST-CLI Does Not Reflect Real World Practice And Will Have Little Value In Guiding Best Treatment For CLTI Which Must Be Individualized |
|
Presenter(s):George L. Adams, MD / Miguel F. Montero-Baker, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:29 PM - 4:34 PM | The SPINACH Registry Shows That Open Bypass Is Better In CLTI With Extensive Gangrene: On The Other Hand, Endo First Is Better In High Risk Patients |
|
Presenter(s):Nobuyoshi Azuma, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:35 PM - 4:40 PM | How To Evaluate Below The Ankle Arteries And Occlusions: CTA And Standard Arteriography Is Inadequate And Some Patent Arteries Will Not Be Seen; Need Distal Interventional Arteriography: How To Do It |
|
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:41 PM - 4:46 PM | Surgery Guided Revascularization And Flow Guided Surgery: What Do They Mean And Why They Are Important To Saving Limbs: Optimal Timing And Type Of Surgery For Gangrene In CLTI: How To Get A Functional Limb |
|
Presenter(s):Giacomo Clerici, MD / Roberto Ferraresi, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:47 PM - 4:52 PM | How To Optimize Endovascular Treatment To Achieve Adequate Foot Perfusion To Heal Foot Wounds In CLTI: How To Measure It; What Are The Variables |
|
Presenter(s):Vikram S. Kashyap, MD / Mehdi H. Shishehbor, DO, MPH, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:53 PM - 4:58 PM | Indocyanine Green Fluorescence (ICG-FL) Is The Best Way To Measure Foot Perfusion After Revascularization: Open Bypass Does Better Than Endo: Why The Angiosome Concept Is More Important After Endo Than Open Procedures |
|
Presenter(s):Maarit Venermo, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 4:59 PM - 5:04 PM | Pedal Temperature Measurements After Revascularization Will Indicate Healing Potential And Optimal Time For Foot Surgery: How To Standardize These Measurements And Make Them Valid |
|
Presenter(s):Wayne J. Caputo, DPM Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:05 PM - 5:11 PM | Panel Discussion |
| END OF SESSION 29 | |
| SESSION 30 SCHEDULE | |
|
Wednesday
SESSION 30:
NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
|
|
| x | |
| INTERMITTENT CLAUDICATION (IC) | |
| 5:11 PM - 5:16 PM | In Patients With IC From SFA Lesions, Stenting Plus Best Medical Treatment (BMT) Improved Quality Of Life And ABI More Than BMT Alone For 2 Years In An RCT |
|
Presenter(s):Hans Lindgren, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:17 PM - 5:22 PM | Why Most Patients With IC Due To SFA Lesions Should Not Undergo Stenting |
|
Presenter(s):Neal S. Cayne, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:23 PM - 5:28 PM | Endovascular Treatments For IC Can Lead To CLTI And Burn Bridges: Causes And Remedies |
|
Presenter(s):Niten Singh, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| ACUTE LIMB ISCHEMIA (ALI) | |
| 5:29 PM - 5:34 PM | Update On Newer Endovascular Thrombosuction Devices For ALI: When Is Open Treatment Required |
|
Presenter(s):Athanasios Katsargyris, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:35 PM - 5:40 PM | Thrombolysis For ALI: Is Its Use Increasing Or Decreasing: Tips In Its Use To Make It Safer By Coupling It With Mechanical Thrombectomy Devices |
|
Presenter(s):Marcus Thieme, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:41 PM - 5:46 PM | Mechanical Endothrombectomy Is Eliminating The Need For Lytic Agents And Making The Treatment Of ALI Safer |
|
Presenter(s):Patrick E. Muck, MD, FACS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:47 PM - 5:52 PM | DEBATE: All Patients With ALI Can And Should Be Treated Endovascularly |
|
Presenter(s):Ali Amin, MD, RVT, FACS, FACC Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:53 PM - 5:58 PM | DEBATE: Not So: Some Patients With ALI Require Open Treatment: Which Ones And Why: Technical Tips |
|
Presenter(s):Joseph L. Mills, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:59 PM - 6:04 PM | New Findings In The Treatment Of ALI: From The Recently Updated European Guidelines: Paradigms Are Changing |
|
Presenter(s):Martin Bjorck, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:05 PM - 6:10 PM | Aspiration Thrombectomy For ALI Due To Thrombosed Popliteal Aneurysms: A Better Way To Treat: Technical Tips And Results |
|
Presenter(s):Frank R. Arko, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:11 PM - 6:20 PM | Panel Discussion End of Program D |
| END OF SESSION 30 | |
| SESSION 31 SCHEDULE | |
|
Wednesday
SESSION 31:
ADVANCES IN MEDICAL TREATMENTS, ANTI-ATHEROGENIC DRUGS AND CARDIAC AND CORONARY ARTERY RISK EVALUATION IN PATIENTS WITH VASCULAR DISEASE
|
|
| x | |
| 6:40 AM - 6:45 AM | What Is Currently The Best Way To Assess Cardiac Risk In Open Vascular Surgery Patients; In Endovascular Treatment Patients |
|
Presenter(s):Peter Henke, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | Fractional Flow Reserve From Coronary CT (FFRCT): What Is It, And It Is A Better Way To Guide Coronary Artery Revascularization |
|
Presenter(s):Gregg W. Stone, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | Value Of Non-Invasive FFRCT In Decreasing Cardiac Complications In Patients Undergoing Lower Extremity Revascularization (Bypasses) And CEAs: It Allows High Risk Asymptomatic Patients To Be Detected Proactively And Treat Better |
|
Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | Improvements In And What Is Coming In Medical Treatment To Prevent Death And Complications From Arteriosclerosis: Update On PCSK-9 Inhibitors Including Inclisiran, Ezetembe, Anti-Inflammatory Drugs And Treating High Lp(a) Levels |
|
Presenter(s):Michael R. Jaff, DO Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | DEBATE: Adherence To Statin Therapy With Attention To Increase Dosage Of High Potency Statins (Atorvastatin And Ruvostatin) Boosts Survival And Is Valuable In The Elderly (> 75): Adverse Effects Are Rare |
|
Presenter(s):Richard Bulbulia, MA MD FRCS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | DEBATE: Statins Are Not A Miracle Drug And Have Been Overvalued: They Have Unrecognized Harmful Effects As Does Excessive Lowering Of LDL Cholesterol (LDL-C): Have We Been Misled And By Whom |
|
Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:16 AM - 7:21 AM | Highlights Of The New AHA Guidelines For Management Of Cholesterol Levels: What LDL-C Levels Should We Strive For In Our Vascular Patients: Why Are Non-HDL Levels A Better Indicator Of Atherosclerotic Risk Than LDL-C Levels |
|
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:22 AM - 7:27 AM | Value Of Lipid Lowering For Treating Plaques In Coronary And Other Arteries: Best Drug Combination And Benefit Of PCSK-9 Inhibitors: How Low Should LDL-C Be Driven: Can Plaques Be Made Smaller And Less Dangerous |
|
Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | Current Value Of Antithrombotic And Antiplatelet Therapy In Vascular Patients: What Drugs Should They Be On – When And Why: The COMPASS RCT Shows That Low Dose Rivaroxaban And Aspirin Decreases Death, Stroke And MI In Vascular Patients: What About Aspirin Alone |
|
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:34 AM - 7:39 AM | How To Detect Vulnerable Plaque (Lipid Rich Plaque [LRP]) And Mortality Risk With New Infrared Spectroscopy (NIRS); How Does It Work: What Can Be Done About LRPs |
|
Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:40 AM - 7:47 AM | Panel Discussion |
| END OF SESSION 31 | |
| SESSION 32 SCHEDULE | |
|
Wednesday
SESSION 32:
MORE ADVANCES IN MEDICAL TREATMENTS; MORE ABOUT NEW DRUGS; STEM CELL TREATMENTS; CATHETER BASED TREATMENTS FOR RESISTANT HYPERTENSION
|
|
| x | |
| MORE ABOUT NEW DRUG TREATMENTS | |
| 7:47 AM - 7:52 AM | New RCT Evidence Shows That An Omega 3 Fatty Acid Formula, Vascepa, Reduces By 25% Major Adverse Cardiac Events In Patients With High Triglycerides (The REDUCE-IT Trial): Bempedoic Acid Reduces LDL-C And C-Reactive Protein: Improved Best Medical Treatment Will Sharply Decrease The Need For Interventional Treatments |
|
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:53 AM - 7:58 AM | Optimal Use Of Direct Oral Anticoagulants (DOACs) After Open Bypasses And After Endovascular Procedures |
|
Presenter(s):Peter Henke, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:59 AM - 8:04 AM | All Vascular Patients Should Be On Statins: What Drug, What Dose: It Matters: There Are Dire Penalties If Statins Are Stopped |
|
Presenter(s):Christos D. Liapis, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| UPDATE ON STEM CELL THERAPY | |
| 8:05 AM - 8:10 AM | Does Stem Cell Therapy Have A Future In The Treatment Of Ischemic Vascular Disease |
|
Presenter(s):Dong-ik Kim, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:11 AM - 8:16 AM | Update On The Value Of Autologous Stem Cell Therapy To Treat Lower Extremity Ischemia: Many Studies Indicate It Helps, But Not Much |
|
Presenter(s):Sigrid Nikol, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| ADVANCES IN CATHETER BASED TREATMENT OF RESISTANT HYPERTENSION | |
| 8:17 AM - 8:22 AM | Current Status And Future Potential Of Endovascular Devices In The Treatment Of Resistant Hypertension: Does Renal Denervation Work |
|
Presenter(s):Sahil A. Parikh, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:23 AM - 8:28 AM | Status Of RCTs And Other Trials Showing The Comparative Value Of Different Catheter Based Techniques For Renal Denervation For Alleviating Resistant Hypertension: Radiofrequency (Spyral – Medtronic), Ultrasound Paradise Catheter (ReCor Medical), And Alcohol Infusion Into Renal Artery Adventitia (Peregrine Catheter, Ablative Solutions); They All Work |
|
Presenter(s):Horst Sievert, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:29 AM - 8:34 AM | Value Of A Stent-Like Mobius HD Device (From Vascular Dynamics) To Reshape The Carotid Sinus, Amplify The Baroreflex And Lower Blood Pressure In Drug Resistant Hypertension |
|
Presenter(s):Gregg W. Stone, MD / Kim J. Hodgson, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:35 AM - 8:40 AM | Update On Value Of ROX Coupler Device To Create An Iliac A-V Fistula And Control Blood Pressure In Resistant Hypertension: How It Works And Results Of A Sham Controlled RCT |
|
Presenter(s):David H. Deaton, MD, FACS / Krishna J. Rocha-Singh, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:41 AM - 8:46 AM | Late Breaking Results Cast Doubt On The Katsanos Meta-Analysis: A Multicenter Study In 2071 Propensity Matched Patients (With CTLI And IC) Shows No Mortality Effect Of Paclitaxel Coated Devices 2 Years After Treatment |
|
Presenter(s):Hany Zayed, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 8:47 AM - 8:54 AM | Panel Discussion |
| 8:54 AM - 9:04 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 32 | |
| SESSION 33 SCHEDULE | |
|
Wednesday
SESSION 33:
PROGRESS IN MANAGING COMPLICATIONS AND ENDOLEAKS AFTER EVAR AND TEVAR
|
|
| x | |
| 9:04 AM - 9:09 AM | Total Aortic Occlusion With Worsening Visceral And Renal Ischemia After TEVAR For Acute TBAD Can Be Due To Complete Dissection Flap Detachment And Distal Migration: Causes And Diagnosis: Urgent Open Flap Excision Is Life-Saving |
|
Presenter(s):Mark K. Eskandari, MD / Heron E. Rodriguez, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:10 AM - 9:15 AM | Major Trauma Can Lead To High Flow Endoleaks In EVAR Patients: What Is The Mechanism: What Is The Best Treatment |
|
Presenter(s):Carlo Setacci, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:16 AM - 9:21 AM | Endoleaks After TEVAR: Incidence, Nature, Etiology, Diagnosis And Treatment |
|
Presenter(s):Maciej L. Dryjski, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:22 AM - 9:27 AM | Natural History Of Type 2 Endoleaks With And Without Treatment: From A 1000 Patient Study |
|
Presenter(s):Carlo Pratesi, MD / Raffaele Pulli, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:28 AM - 9:33 AM | Little Known Facts About Endoleaks After EVAR: Natural History Of Late Type 1 Endoleaks Is Not Benign – Urgent Treatment Is Required: An Enlarging AAA Sac With A Type 2 Endoleak Usually Indicates The Presence Of An Associated Type 1 Endoleak |
|
Presenter(s):O. William Brown, MD, JD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:34 AM - 9:39 AM | Value Of CT Fusion Guidance And Liquid Embolic Agents To Treat Type 2 Endoleaks: Technical Tips And How To Do It With The Best Chance Of Success |
|
Presenter(s):Neal S. Cayne, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:40 AM - 9:45 AM | How Common Are Failures Of Interventions For Type 2 Endoleaks: What Are The Reasons And When Is Open Treatment Indicated: What Should That Open Treatment Be |
|
Presenter(s):Ronald M. Fairman, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:46 AM - 9:51 AM | Minimizing Type 2 Endoleaks With Careful Imaging And Pre-EVAR Side Branch Coiling: It Works: Technical Tips |
|
Presenter(s):Götz M. Richter, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 9:52 AM - 9:59 AM | Panel Discussion |
| 9:59 AM - 10:04 AM | Transgraft Access And Onyx Embolization For Type 2 Endoleaks Difficult To Approach And Treat: Technique And Results |
|
Presenter(s):Mark W. Mewissen, MD, RVT Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:05 AM - 10:10 AM | Optimal Strategy For And Results Of Treating Type 2 Endoleaks: It Is Not Simple |
|
Presenter(s):Sonia Ronchey, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:11 AM - 10:16 AM | Role Of Anticoagulation And Endogenous Thrombolysis In The Occurrence And Resolution Of Late Type 2 Endoleaks: How Should They Influence Treatment |
|
Presenter(s):Natzi Sakalihasan, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:17 AM - 10:22 AM | Value Of Fibrin Glue Sac Filling With EVAR To Prevent Type 2 Endoleaks: Technique, Value And Limitations |
|
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:23 AM - 10:28 AM | Sac Access Routes To Treat Type 2 Endoleaks: Techniques, Advantages And Limitations Of Each |
|
Presenter(s):Joshua D. Adams, MD / Claudio J. Schonholz, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:29 AM - 10:34 AM | Treating Type 2 Endoleaks By A Paragraft Approach: Indications, Technique And Results |
|
Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:35 AM - 10:40 AM | How Does Endograft Covering Material (Polyester vs. PTFE) Influence Type 2 Endoleak Rates And Behavior After EVAR |
|
Presenter(s):Ross Milner, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:41 AM - 10:46 AM | Value Of Liquid Embolic Agents And Onyx In Treating Type 1 And Type 2 Endoleaks: Technical Tips And Results |
|
Presenter(s):Robert A. Morgan, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:47 AM - 10:52 AM | Importance Of Recognizing Visceral Artery Occlusive Disease Before Performing EVAR: How To Diagnose And Treat |
|
Presenter(s):Karan Garg, MD / Neal S. Cayne, MD / Carlos H. Timaran, MD / Frank J. Veith, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 10:53 AM - 11:00 AM | Panel Discussion |
| END OF SESSION 33 | |
| SESSION 34 SCHEDULE | |
|
Wednesday
SESSION 34:
RECORDED LIVE CHALLENGING AND COMPLEX CASES FROM LINC AND LEIPZIG
Location: Grand Ballroom West, 3rd Floor
Moderators:Dierk Scheinert, MD / Giancarlo Biamino, MD, PhD / Andrej Schmidt, MD |
|
| x | |
| 11:00 AM - 11:20 AM | Vessel Preparation By Mechanical Debulking Using The Rotarex Atherectomy System; Including Recorded Case Presentation |
|
Presenter(s):Andrej Schmidt, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:20 AM - 11:40 AM | Minimally Invasive Solutions For Challenging Peripheral Occlusions: The PQ-Bypass Technique; Including Recorded Case Presentation |
|
Presenter(s):Mark A. Adelman, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:40 AM - 11:50 PM | Optimizing Results Of BTK Procedures: Latest Data On BTK DCB From The AcoARt BTK Study And Optimization Of Recanalization Results With Tack BTK Scaffolds; Including Recorded Case Presentation |
|
Presenter(s):Dierk Scheinert, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 11:50 AM - 12:00 PM | DCB And Tack Treatment Of BTK CTOs |
|
Presenter(s):Andrej Schmidt, MD Location: Grand Ballroom West, 3rd Floor |
|
| 12:00 PM - 12:50 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 34 | |
| SESSION 35 SCHEDULE | |
|
Wednesday
SESSION 35:
CHALLENGING RECORDED LIVE CASES AND THOSE EMPLOYING INNOVATIVE TECHNIQUES
Location: Grand Ballroom West, 3rd Floor
Moderators:Fabrizio Fanelli, MD, EBIR / Andrew Holden, MBChB / Carlo Setacci, MD / Frank J. Veith, MD |
|
| x | |
| 12:50 PM - 12:57 PM | When Is A Technically Successful Arterialization Of The Foot Veins Effective In Preventing Amputation In No-Option CLI Patients |
|
Presenter(s):Roberto Ferraresi, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 12:57 PM - 12:59 PM | Discussion |
| 12:59 PM - 1:06 PM | Open Surgery For Infra- And Juxtrarenal AAA In The Endovascular Era |
|
Presenter(s):Dittmar Boeckler, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:06 PM - 1:08 PM | Discussion |
| 1:08 PM - 1:15 PM | Unexpected Initial And Final Completion Angiogram For A First In Human Fenestrated Endograf |
|
Presenter(s):Vicente Riambau, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:15 PM - 1:17 PM | Discussion |
| 1:17 PM - 1:24 PM | Single Session Venous Thrombectomy For Acute Ilio-Femoral Deep Vein Thrombosis: The Advantages Of ZERO Thrombolysis |
|
Presenter(s):Gerard J. O'Sullivan, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:24 PM - 1:26 PM | Discussion |
| 1:26 PM - 1:33 PM | Most Successful Tools For Complex Femoropopliteal CTO Recanalizations |
|
Presenter(s):Andrej Schmidt, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:33 PM - 1:35 PM | Discussion |
| 1:35 PM - 1:42 PM | Endovascular Management Of Complex Fem-Pop And Below Lesions In 2019 |
|
Presenter(s):Lorenzo Patrone, MD / Fabrizio Fanelli, MD, EBIR Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:42 PM - 1:44 PM | Discussion |
| 1:44 PM - 1:51 PM | Vessel Preparation – Is It Relevant In The Tibial Arteries |
|
Presenter(s):Andrew Holden, MBChB Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 1:51 PM - 1:53 PM | Discussion |
| 1:53 PM - 1:59 PM | Panel Discussion |
| END OF SESSION 35 | |
| SESSION 36 SCHEDULE | |
|
Wednesday
SESSION 36:
TRIBUTE TO A VALUED PARTNER; IMPORTANT ISSUES RELATED TO VASCULAR PRACTICE AND VASCULAR SURGEONS
|
|
| x | |
| 2:00 PM - 2:05 PM | A Tribute To Sushil K. Gupta, MD, MBA (1949-2019) – A Creative And Talented Surgeon, A Brilliant Innovator And A Treasured Colleague And Friend |
|
Presenter(s):Larry A. Scher, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:06 PM - 2:11 PM | Trials And RCTs Versus Registries: Advantages And Disadvantages Of Each: How Can We Reach The Truth |
|
Presenter(s):Charles C. Miller, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | Keys To A Successful Career In Vascular Surgery |
|
Presenter(s):Ronald L. Dalman, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | How Vascular Surgeons Can Develop Leadership Skills |
|
Presenter(s):Robert B. McLafferty, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | How Women Vascular Surgeons Look Differently At Gender Differences In Procedural Results Than Their Male Counterparts And Why This Is Advantageous For Female Patients |
|
Presenter(s):Rebeca Reachi Lugo, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | How To Teach Competent Open Surgery In The Endovascular Era |
|
Presenter(s):R. Clement Darling III, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | Vascular Surgery Burnout: Why It Occurs: Is It Related To Occupational Or Ergonomic Ailments And Pain: What Can Be Done To Prevent And Fix The Problem |
|
Presenter(s):Samuel R. Money, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | What Constitutes Futility In Our Present Health Care System: When Is Enough Too Much |
|
Presenter(s):James W. Jones, MD, PhD, MHA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | Panel Discussion |
| 2:53 PM - 2:58 PM | Lessons Learned By A Creative Physician-Inventor: How To Avoid The Pitfalls In Bringing An Idea To Fruition Without Losing Your Idea Or Your Shirt |
|
Presenter(s):Lindsay Machan, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:59 PM - 3:04 PM | How Are Silicon Valley Giants And Entrepreneurs Planning To Disrupt Health Care: Will It Improve Things For Patients; For Doctors; For Vascular Specialists |
|
Presenter(s):Ido Weinberg, MD, MSc Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:05 PM - 3:10 PM | Screening For Vascular Diseases Can Cause More Harm Than Benefit: How To Avoid This Problem |
|
Presenter(s):Anders Wanhainen, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:11 PM - 3:16 PM | Variations Around The World In The Treatment Of AAAs And Carotid Stenosis Patients: What Are The Implications: From The Consortium Of Vascular Registries |
|
Presenter(s):Jack L. Cronenwett, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:17 PM - 3:22 PM | Are There Problems With The Appropriateness Of Invasive Treatment By Vascular Surgeons, By Other Vascular Specialists |
|
Presenter(s):Peter F. Lawrence, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:23 PM - 3:28 PM | The Hospital Readmission Reduction Program And Its Incentives Have Led To Increased Morbidity And Mortality For Vascular Patients: How Can It Be Fixed To Make It Safe |
|
Presenter(s):Philip P. Goodney, MD, MS / Janet T. Powell, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:29 PM - 3:34 PM | What Is The Impact Of The New AAA DRGs On Hospital Reimbursement: Does More Have To Be Done |
|
Presenter(s):W. Charles Sternbergh III, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:35 PM - 3:40 PM | Panel Discussion |
| 3:40 PM - 3:48 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 36 | |
| SESSION 37 SCHEDULE | |
|
Wednesday
SESSION 37:
ISSUES RELATED TO VASCULAR OUTPATIENT CENTERS, OFFICE BASED LABS AND MEDICAL ETHICS
|
|
| x | |
| 3:48 PM - 3:53 PM | Why Outpatient Centers And Office Based Labs (OBLs) Are The Best Place To Do Which Endovascular Procedures: Best For Patients And Best For Operators: When Can Atherectomies Be Performed Safely There; When Not |
|
Presenter(s):Krishna Jain, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 3:54 PM - 3:59 PM | Real World Results Of Lower Extremity Atherectomy (Mostly In Outpatient Centers) From Medicare Billing Data Is Much Worse Than Favorable Registry Data: Where Lies The Truth |
|
Presenter(s):Dipankar Mukherjee, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:00 PM - 4:05 PM | How To Avoid Unethical Practices In An Outpatient Center Or Office Based Lab (OBL): The Temptation And Incentives To Overtreat Is Great |
|
Presenter(s):Stephen M. Bauer, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:06 PM - 4:11 PM | Characteristics Of Physicians Who Are Suited To Work In An OBL And Characteristics Of Those Who Are Not |
|
Presenter(s):Sam S. Ahn, MD, FACS, MBA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:12 PM - 4:17 PM | Office Based Versus Hospital Based Vascular Care: Impact On Indications, Physician Income And Overall Costs |
|
Presenter(s):Clifford M. Sales, MD, MBA, FACS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:18 PM - 4:23 PM | Another View Of The Impact Of Office Based Vascular Practice Patterns On Indications, Physician Incomes And Outcomes |
|
Presenter(s):Matthew W. Mell, MD, MS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:24 PM - 4:29 PM | A Propensity Matched Comparison Of Paclitaxel Coated DCBs Versus POBA In Patients With Intermittent Claudication: 5-Year Results Show No Increased Mortality Signal For DCBs |
|
Presenter(s):Georgios A. Pitoulias, MD, PhD / Konstantinos P. Donas, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:30 PM - 4:35 PM | Vascular Screening Is Often Unnecessary, Possibly Harmful And Largely Driven By Financial Gain: When Is It Justified And Beneficial To Patients |
|
Presenter(s):Frank J. Criado, MD, FACS, FSVM Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:36 PM - 4:41 PM | Advantages To A Vascular Practice Of Having A Wound Care Center |
|
Presenter(s):Venita Chandra, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:42 PM - 4:47 PM | Benefits To A Vascular Practice And Hospital Of Having A Limb Salvage Program: How To Set One Up And Make It Work |
|
Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS, FACS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 4:48 PM - 4:55 PM | Panel Discussion |
| END OF SESSION 37 | |
| SESSION 38 SCHEDULE | |
|
Wednesday
SESSION 38:
TOPICS RELATED TO THE FDA, VALUE OF A VASCULAR SURGEON, VASCULAR PRACTICE, THE SVS, VQI AND GOVERNMENTAL REGULATIONS AND REIMBURSEMENT
|
|
| x | |
| 4:55 PM - 5:00 PM | How Innovative Vascular Devices Can Get To Market: What Is The De Novo Pathway |
|
Presenter(s):Dorothy B. Abel, BSBME Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:01 PM - 5:06 PM | What Is The Value Of A Vascular Surgeon To A Health Care System In And Out Of The Operating Room: In Many Ways It Is Priceless But Under-Rewarded |
|
Presenter(s):Richard J. Powell, MD / Fred A. Weaver, MD, MMM Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:07 PM - 5:12 PM | How Can Vascular Surgeons Best Cope In A MIPS And MACRA World: What Will Happen With The Medical Device Excise Tax In 2020 And Why Its Repeal Is Important To Vascular Surgeons And Vascular Specialists |
|
Presenter(s):Robert M. Zwolak, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:13 PM - 5:18 PM | What Is On The Horizon For Vascular Surgeons And Vascular Specialists Reimbursement: Will Income Go Up Or Down For The Same Amount Of Work |
|
Presenter(s):Sean P. Roddy, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:19 PM - 5:24 PM | Opposite Trends In Reimbursement By CMS For Arterial And Venous Procedures: Implications For Vascular Surgery Practices |
|
Presenter(s):Thomas F. O'Donnell, Jr., MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:25 PM - 5:30 PM | Revascularization For CLTI By Endovascular Treatments Or Open Surgery Is Cost Effective And Saves Lives Compared To Major Amputations |
|
Presenter(s):Richard F. Neville, MD / Jihad A. Mustapha, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:31 PM - 5:36 PM | How To Shorten Lengths Of Stay After Vascular Open Surgery Or Interventions: It Is Not Easy, But It Is Doable |
|
Presenter(s):Fred A. Weaver, MD, MMM Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:37 PM - 5:42 PM | Progress In And Value Of The SVS VQI Program: Where Is It Going And Why Will It Become Increasingly Important |
|
Presenter(s):Jack L. Cronenwett, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:43 PM - 5:48 PM | Improvements In Vascular Specialist, The SVS Newspaper: Opportunities And Challenges And How It Can Benefit Vascular Surgeons And Others |
|
Presenter(s):Malachi Sheahan, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:49 PM - 5:54 PM | Recent Improvements In The JVS: How To Get A Paper Accepted In The JVS: How Best To Review A Paper For The JVS |
|
Presenter(s):Peter Gloviczki, MD / Peter F. Lawrence, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:55 PM - 6:02 PM | Panel Discussion End of Program E |
| END OF SESSION 38 | |
| SESSION 39 SCHEDULE | |
|
Wednesday
SESSION 39:
MORE TOPICS RELATED TO NEW DEVELOPMENTS IN TREATING AORTIC DISSECTIONS AND ITS COMPLICATIONS
|
|
| x | |
| 6:40 AM - 6:45 AM | Retrograde SMA Stenting May Be The Best Way To Treat Mesenteric Compromise From Malperfusion With Aortic Dissections: How To Do It And Results |
|
Presenter(s):Dipankar Mukherjee, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | When Can The Celiac Trunk Orifice Be Covered Safely During TEVAR And When Not: From A New Meta-Analysis |
|
Presenter(s):Wayne W. Zhang, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | Left Subclavian Revascularization During Zone 2 TEVARs: Comparison Of Open Surgical Bypass Versus Endovascular Revascularization With Parallel Grafts (Chimney Or Periscope) |
|
Presenter(s):Giovanni Pratesi, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | When Should False Lumen Thrombosing Techniques Be Used In Patients With TBADs: How Best To Do It |
|
Presenter(s):Thomas L. Forbes, MD / Cherrie Z. Abraham, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | New Technique For False Lumen Occlusion In Chronic Aortic Dissections: Using A Physician Modified Device: How To Do It And Results |
|
Presenter(s):I-Hui Wu, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | New Proximal And Distal Re-Entry Tears After TEVAR: What Are The Causative Mechanisms, Risk Factors And Treatments |
|
Presenter(s):Ludovic Canaud, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:16 AM - 7:21 AM | Another View On Endograft Induced Distal Re-Entry Tears After TEVAR: Strategies To Prevent, Diagnose And Treat |
|
Presenter(s):Martin Czerny, MD / Bartosz Rylski, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:22 AM - 7:27 AM | Best Treatment Options For Aortic Dissections In Patients With Connective Tissue Disorders: When Endo; When Open; When Hybrid |
|
Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | EVAR And TEVAR Can Work Surprisingly Well In Some Aneurysm Patients With Connective Tissue Disorders; When And When Not: Technical Tips |
|
Presenter(s):Tilo Koelbel, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:34 AM - 7:39 AM | With TBADs, What Are The Flow/Pressure Dynamics That Explain Why TEVAR Can Make Things Worse |
|
Presenter(s):Firas F. Mussa, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:40 AM - 7:45 AM | Advantages To Hybrid Approaches To Complex Aortic And Aortovisceral Artery Pathology: Indications And Technical Tips |
|
Presenter(s):William J. Quinones-Baldrich, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 7:46 AM - 7:54 AM | Panel Discussion |
| END OF SESSION 39 | |
| SESSION 40 SCHEDULE | |
|
Wednesday
SESSION 40:
MORE NEW DEVELOPMENTS RELATED TO THE ASCENDING AORTA, AORTIC ARCH, F/B/TEVAR AND PARALLEL GRAFTS FOR TREATMENT OF LESIONS IN OR NEAR THE AORTIC ARCH
|
|
| x | |
| 7:54 AM - 7:59 AM | Wrapping Of The Dilated Ascending Aorta To Avoid More Complex Procedures And Facilitate Placement Of Grafts To Arch Branches: Indications, Contraindications, Technical Tips And Results |
|
Presenter(s):Mario L. Lachat, MD / Ralf R. Kolvenbach, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:00 AM - 8:05 AM | Variations In The Morphology Of Proximal Entry Tears In TBADs: Importance Of These Variations And How Should They Influence Treatment |
|
Presenter(s):Ali Azizzadeh, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:06 AM - 8:11 AM | Significance Of Aortic Arch Anomalies: What Are They Associated With: When Do They Require Treatment: What Is The Best Current Treatment |
|
Presenter(s):Erik E. Debing, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:12 AM - 8:17 AM | What Do Fluid Dynamics Tell Us About The Durability And Long-Term Results Of Aortic Arch Branch And Fenestrated Endografts |
|
Presenter(s):Santi Trimarchi, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:18 AM - 8:23 AM | 3-Branch Endograft For Aortic Arch Aneurysm Repair (From Terumo Aortic): Advantages, Limitations And Results To Date |
|
Presenter(s):W. Anthony Lee, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:24 AM - 8:29 AM | Unusual Branched Endograft Solutions For Aortic Arch Lesions When Industry-Made Commercial Devices Are Unavailable Or Unsuitable |
|
Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:30 AM - 8:35 AM | How Best To Treat TBADs Extending Into The Arch And Ascending Aorta |
|
Presenter(s):I-Hui Wu, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:36 AM - 8:41 AM | Value Of Chimney TEVAR (Ch/TEVAR) To Treat Elective And Ruptured Aneurysms Involving The Aortic Arch: A 15-Year Experience And Results |
|
Presenter(s):Thomas Larzon, MD, PhD / Tal M. Hörer, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:42 AM - 8:47 AM | Ch/TEVAR In The Aortic Arch If Done Right Is As Good As F/B/TEVAR And Safer Than Open Surgery: Technical Tips And Results |
|
Presenter(s):Armando C. Lobato, MD, PhD / Jan S. Brunkwall, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:48 AM - 8:53 AM | Update On Sandwich Grafts For Zone 0 Aortic Arch Lesions: 8-Year Results And Technical Tips |
|
Presenter(s):Armando C. Lobato, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 8:54 AM - 9:02 AM | Panel Discussion |
| END OF SESSION 40 | |
| SESSION 41 SCHEDULE | |
|
Wednesday
SESSION 41:
MORE ABOUT JUXTA- AND PARARENAL AAAs, TAAAs, F/B/EVAR AND PARALLEL GRAFTS (CHIMNEY EVAR [Ch/EVAR])
|
|
| x | |
| 9:02 AM - 9:07 AM | A New And Better Way To Define And Classify AAA Neck Anatomy And Indicate Best Treatment |
|
Presenter(s):David J. Minion, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:08 AM - 9:13 AM | For Juxta- And Pararenal AAAs Ch/EVAR Can Yield Dependably Good And Durable Results If Certain Technical Requirements Are Followed And Certain Device Combinations Are Used: Results From The ENCHANT Registry |
|
Presenter(s):Giovanni Torsello, MD / Konstantinos P. Donas, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:14 AM - 9:19 AM | Ch/EVAR For Juxta And Pararenal AAA: Technical Tips To Assure Good Long-Term Results: A 9-Year Experience |
|
Presenter(s):Nicola Mangialardi, MD / Sonia Ronchey, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:20 AM - 9:25 AM | Indications For Chimney And Sandwich Grafts In The F/B/EVAR Era: Yes They Exist |
|
Presenter(s):Martin Malina, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:26 AM - 9:31 AM | Repair Of Juxta- And Pararenal AAAs Using A Combination Of Fenestrations And Chimney Grafts: Advantages, Techniques And Results |
|
Presenter(s):Mark W. Mewissen, MD, RVT Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:32 AM - 9:37 AM | How To Rescue A F/EVAR Procedure When The Fenestrations Are Poorly Aligned With Branch Orifices: Why Does It Happen |
|
Presenter(s):Gustavo S. Oderich, MD, FACS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:38 AM - 9:43 AM | Main Graft Body Alignment With Branch Orifices Is Not An Issue With Parallel Grafts (Ch/EVAR) And How Do Variable Curvature Sheaths Help With Both F/EVAR And Ch/EVAR |
|
Presenter(s):Jason T. Lee, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:44 AM - 9:49 AM | DEBATE: Long-Term Results Of F/B/EVAR For Pararenal AAAs Show That It Should Be The Procedure Of Choice And TAAAs In Anatomically Suited Patients Which Is Most Of The Time |
|
Presenter(s):Piergiorgio Cao, MD, FRCS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:50 AM - 9:55 AM | DEBATE: Not So: Open Repair Still Has A Major Role For Treating Many Patients With Pararenal AAAs And TAAAs |
|
Presenter(s):Thomas C. Bower, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 9:56 AM - 10:01 AM | United Kingdom Assessment Of Countrywide Outcomes And Cost For Treating Complex AAAs: Is Endo Equal To Or Better Than Open Repair In Any Way |
|
Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:02 AM - 10:10 AM | Panel Discussion |
| 10:10 AM - 10:20 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 41 | |
| SESSION 42 SCHEDULE | |
|
Wednesday
SESSION 42:
UPDATE ON MULTILAYER FLOW MODULATING BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS; NEW DEVELOPMENTS IN TREATING ILIAC ANEURYSMS AND REVASCULARIZING HYPOGASTRIC ARTERIES
|
|
| x | |
| UPDATE ON MULTILAYER FLOW MODULATING BARE STENTS | |
| 10:20 AM - 10:25 AM | Multilayer Flow Modulating (MLFM) Uncovered Stents (From Cardiatis): Indications, Contraindications, Advantages And Results |
|
Presenter(s):Rodney A. White, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:26 AM - 10:31 AM | Why MLFM Uncovered Stents Should Be The First Choice For Treating Renal, Visceral And Popliteal Aneurysms And Possibly Other Lesions: Results Show That These Stents Preserve Branch Flow And Prevent Aneurysm Rupture |
|
Presenter(s):Michel C. Henry, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:32 AM - 10:37 AM | Role Of MLFM Uncovered Stents To Treat Type A Aortic Dissections: Indications, Advantages, Limitations And Results |
|
Presenter(s):Victor S. Costache, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:38 AM - 10:43 AM | Value Of MLFM Uncovered Stents To Treat Aortic Dissections And Recurrent Emboli From Paroxysmal Atrial Fibrillation: They Prevent Emboli From Going To The Brain |
|
Presenter(s):Ralf R. Kolvenbach, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:44 AM - 10:49 AM | Role Of MLFM Stents For Treating Type A And B Aortic Dissections: Indications And Results: What About For Complex Aneurysm Treatment |
|
Presenter(s):Zoran Stankov, MD / Ivo Petrov, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:50 AM - 10:55 AM | MLFM Uncovered Stents For Treating Complex AAAs And TAAAs: What Do The Longer-Term Results From The Multicenter DRAGON Trial Show: Do These Stents Prevent Rupture |
|
Presenter(s):Claude D. Vaislic, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 10:56 AM - 11:01 AM | Long-Term Follow-Up Of Multilayer Bare Stent Treatment Of TAAAs, Complex AAAs And Type B Aortic Dissections: The Moroccan Experience |
|
Presenter(s):Amira Benjelloun, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:02 AM - 11:07 AM | Panel Discussion |
| TREATMENT OF ILIAC ANEURYSM AND PRESERVING HYPOGASTRIC FLOW | |
| 11:07 AM - 11:12 AM | Comparing The Various Industry-Made Iliac Branch Devices (IBDs) For Treating Common And Internal Iliac Aneurysms: Advantages And Limitations Of Each: When To Use Which One |
|
Presenter(s):Fabio Verzini, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:13 AM - 11:18 AM | Advantages, Limitations And Results Of Unilateral And Bilateral Gore IBD To Treat AAAs With Iliac Aneurysms: Early Results From The International ICEBERG Registry |
|
Presenter(s):Michel M.P. Reijnen, MD, PhD / Thomas S. Maldonado, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:19 AM - 11:24 AM | How To Prevent Complications And Failure With The Gore IBD When The Anatomy Is Tortuous: What Is The Iliac Tortuosity Index And How Does It Help |
|
Presenter(s):Jon S. Matsumura, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:25 AM - 11:30 AM | Value Of IBDs To Treat Isolated (No AAA) Common And Internal Iliac Aneurysms: At What Size Should They Be Treated: Which Device Is Best |
|
Presenter(s):Giovanni Pratesi, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:31 AM - 11:36 AM | Advantages And Limitations Of The Jotec-Cryolife IBD For Treating Common And Internal Iliac Aneurysms; This Device Works Well With The Endurant Endograft (Medtronic) |
|
Presenter(s):Lee Bouwman, MD, PhD, MSc Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:37 AM - 11:42 AM | When The Anatomy Is Not Suitable For An IBD, How Can Hypogastric Flow Be Preserved: Sandwich Grafts, External Iliac-To-Hypogastric Grafts Open Or Endo With An Aorto-Uni-Iliac EVAR, Etc. |
|
Presenter(s):Martin R. Back, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:43 AM - 11:48 AM | How Common Iliac Aneurysms (CIAs) Have An Impact On Aortic Morphology: Why A New Classification System For CIAs Will Be Helpful |
|
Presenter(s):Janet T. Powell, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 11:49 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – 2nd Floor PromenadeVisit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 42 | |
| SESSION 43 SCHEDULE | |
|
Wednesday
SESSION 43:
INTERESTING NEW DEVELOPMENTS IN STANDARD EVAR AND INFRARENAL AAAs: ACCEPTABLE NECK ANATOMY; NEW GUIDELINES; AAA SAC THROMBUS AND SHRINKAGE; NEW CLASSIFICATION SYSTEM; EFFECT OF STEROIDS ON EVAR
Location: Trianon Ballroom, 3rd Floor
Moderators:Elliot L. Chaikof, MD, PhD / Janet T. Powell, MD, PhD |
|
| x | |
| 1:00 PM - 1:05 PM | AAA Sac Shrinkage Is A Good Marker Of Durable Success After EVAR: Which Endografts Have The Best Rates Of Sac Shrinkage |
|
Presenter(s):Michael C. Stoner, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Large Diameter Of The Flow Lumen In AAAs Is A Risk Factor For A Poor Outcome After EVAR Just Like Large Proximal Neck Diameter: What Are The Reasons For These Observations |
|
Presenter(s):Hence J.M. Verhagen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Large Proximal Necks (> 28 mm In Diameter) Are Predictive Of A Poor Outcome From EVAR: Based On A Meta-Analysis |
|
Presenter(s):Matt M. Thompson, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Highlights From The New 2019 European (ESVS) AAA Guidelines: What Is Different And Better About Them |
|
Presenter(s):Sebastian E. Debus, MD, PhD / Anders Wanhainen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Comparison Of The US (SVS) And ESVS AAA Guidelines: Why Are The US Guidelines Better |
|
Presenter(s):Ronald L. Dalman, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Increasing Disparity Between The SVS Guideline AAA Indications For AAA Repair And Real World Practice: Are The Guidelines Relevant Currently |
|
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | DEBATE: Increasing Volume Of Mural Clot Within An AAA Sac Does Not Increase The Rupture Risk |
|
Presenter(s):Athanasios D. Giannoukas, MSc, MD, PhD, FEBVS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | DEBATE: Not So: Increasing Thrombus Volume Within An AAA Sac Correlates With Increasing Risk Of Complications And Rupture: What Is The Mechanism |
|
Presenter(s):David H. Deaton, MD, FACS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | A New Classification System For AAAs Helps In Understanding Their Behavior, In Determining Treatments And Evaluating Them |
|
Presenter(s):Claude Mialhe, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | Does Preprocedure Steroid Administration Before EVAR Produce A More Benign Postprocedure Course And Facilitate Earlier Discharge: What Is The Mechanism |
|
Presenter(s):Lars B. Lonn, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:00 PM - 2:06 PM | Panel Discussion |
| END OF SESSION 43 | |
| SESSION 44 SCHEDULE | |
|
Wednesday
SESSION 44:
MORE NEW DEVELOPMENTS IN AAA PATHOGENESIS, NATURAL HISTORY AND TREATMENT
|
|
| x | |
| 2:06 PM - 2:11 PM | Inflammatory AAAs: Medical Treatment With Steroids Is Adequate For Many Patients With Them: What Is The Regimen And Results: When Is Invasive Treatment Needed – Open Or Endo |
|
Presenter(s):Julien G. Sfeir, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | How Long Can Patients With Moderate Sized AAAs Safely Wait For Elective Repair: Rupture Risk For AAAs < 6.0 cm In Diameter Is Low And Overemphasized |
|
Presenter(s):Richard G.J. Gibbs, FRCS Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | Acceptable Results Can Be Achieved With EVAR Devices Used Outside IFU Requirements If Certain Precautions Are Followed: What Are They And What Are The Limitations |
|
Presenter(s):Francesco Speziale, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | Depleted Nutritional Status And Muscle Mass Increases The Risk Of Open AAA Repair: What About With EVAR |
|
Presenter(s):Kimihiro Komori, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | Why F/EVAR For Failed EVAR Is Not Simple: Technical Tips To Make It Work |
|
Presenter(s):Barend M.E. Mees, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | A New Gene Family That May Be Vital In Causing AAAs: The Gene Can Be Identified From Skin Biopsies: How Can They Help In Diagnosis And Treatment |
|
Presenter(s):Kak Khee Yeung, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | Comparison Of Aortic Neck Dilatation After AAA Repair In Patients Undergoing EVAR Versus Open Repair: From The DREAM Trial Which Allows This Comparison To Be Made In Patients Suitable For Both Procedures |
|
Presenter(s):Jan D. Blankensteijn, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | How Should AAA Shape (With An Eccentric Sac Or Two Sacs) Influence Indications For Repair: How Should Diameter Measurements Be Made In These Circumstances |
|
Presenter(s):Jacques Busquet, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 2:54 PM - 3:00 PM | Increasing Requirement For Open Conversion Following EVAR: Reasons For And Technical Tips: Why Is It More Often Required For A Persistent Type 2 Endoleak With An Enlarging AAA Sac |
|
Presenter(s):Michel Makaroun, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:00 PM - 3:15 PM | Panel Discussion And BreakVisit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 44 | |
| SESSION 45 SCHEDULE | |
|
Wednesday
SESSION 45:
SHORT HOT NEW TOPICS RELATED TO AORTIC DISEASES AND THEIR TREATMENT (4 ¾- MINUTE FAST PACED TALKS)
|
|
| x | |
| EVAR AND AAA RELATED TOPICS | |
| 3:15 PM - 3:20 PM | External Iliac To Internal Iliac Artery Bypass: Does It Have A Role In Preserving Hypogastric Flow In The Endo Era: Technical Tips |
|
Presenter(s):Heron E. Rodriguez, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:20 PM - 3:25 PM | Value And Indications For Preprocedural Embolization Of The IMA And Lumbar Arteries Before EVAR |
|
Presenter(s):Timothy M. Sullivan, MD / Jesse Manunga, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:25 PM - 3:30 PM | Increasing Role Of Endovascular Treatments And EVAR For Vascular Complications Of Connective Tissue Disorders |
|
Presenter(s):Anders Wanhainen, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:30 PM - 3:35 PM | Why Should Aortic AAA Neck Dilatation Differ After EVAR And After F/EVAR: Does It |
|
Presenter(s):Thomas S. Maldonado, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:35 PM - 3:40 PM | EVAR Treatment Of Atypical AAAs: Technical Tips And Special Precautions |
|
Presenter(s):Furuzan Numan, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:40 PM - 3:45 PM | 5 Years After AAA Repair The Quality Of Life Is Better In Those Having EVAR Than In Those Having Open Repair |
|
Presenter(s):Mauro Gargiulo, MD / Gianluca Faggioli, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:45 PM - 3:50 PM | Why Do Fluoroquin Drugs Increase The Risk Of Aortic Aneurysms And Dissections |
|
Presenter(s):Natzi Sakalihasan, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 3:50 PM - 3:55 PM | Panel Discussion |
| F/B/EVAR AND PARALLEL GRAFT RELATED TOPICS | |
| 3:55 PM - 4:00 PM | When With F/EVAR Should A Renal Or Mesenteric Branch Not Be Stented |
|
Presenter(s):Benjamin W. Starnes, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:00 PM - 4:05 PM | Avoid Complications And Problems From Parallel Grafts And How To Make Them Work Safely And Effectively |
|
Presenter(s):Murray L. Shames, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:05 PM - 4:10 PM | Update On In Situ Fenestration For Branch Revascularization: How To Use It For Renal And Mesenteric Branches In Urgent TAAA Repairs: Imaging Is Key And It Is Not Simple |
|
Presenter(s):Jean M. Panneton, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:10 PM - 4:15 PM | Multicenter Results Of The t-Branch Off-The-Shelf Graft (From Cook) For TAAA Repairs: Advantages, Technical Tips, Limitations |
|
Presenter(s):Martin J. Austermann, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| AORTIC DISSECTION RELATED TOPICS | |
| 4:15 PM - 4:20 PM | The SKIRT Stent-Graft To Prevent Endoleaks From Fenestrated And Chimney TEVARs: How Does It Work |
|
Presenter(s):Chang Shu, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:20 PM - 4:25 PM | Troubleshooting Challenging TBADs During Endovascular Treatment And Making TEVAR Work Safely And Effectively |
|
Presenter(s):Rami Tadros, MD / Michael L. Marin, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:25 PM - 4:30 PM | Branched Endografts For Treating Aortic Dissections: Which Graft For Which Patient And Anatomy: Technical Tips |
|
Presenter(s):Luis A. Sanchez, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:30 PM - 4:35 PM | Panel Discussion |
| END OF SESSION 45 | |
| SESSION 46 SCHEDULE | |
|
Wednesday
SESSION 46:
MORE SHORT HOT NEW TOPICS RELATED TO AORTIC AND CAROTID DISEASES AND THEIR TREATMENT (4 ¾-MINUTE FAST PACED TALKS)
Location: Trianon Ballroom, 3rd Floor
Moderators:Luis A. Sanchez, MD / K. Wayne Johnston, CM, MD, FRCS |
|
| x | |
| AORTA RELATED TOPICS | |
| 4:35 PM - 4:40 PM | International Comparison Of How AAAs Are Treated And How It Influences Results |
|
Presenter(s):Pete Holt, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:40 PM - 4:45 PM | Long-Term Outcomes From The OVER RCT Comparing AAA Treatment With EVAR Versus Open Repair: How Are Results Similar And How Do They Differ From The EVAR 1 And DREAM RCTs And Why |
|
Presenter(s):Jon S. Matsumura, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:45 PM - 4:50 PM | At What Size Do Hypogastric Aneurysm Need To Be Treated: How Best To Do It And Technical Tips |
|
Presenter(s):Darren B. Schneider, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:50 PM - 4:55 PM | Safe F/B/EVAR In Patients With Chronic Kidney Disease: Intravascular Ultrasound (IVUS) Helps: Technical Tips |
|
Presenter(s):Carlos H. Timaran, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 4:55 PM - 5:00 PM | Acute Kidney Injury During F/B/EVAR: What Are The Long-Term Consequences And What Can Be Done To Prevent Or Treat It Better |
|
Presenter(s):Andres Schanzer, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:00 PM - 5:05 PM | Why Outcomes Of F/B/EVAR For Women Are Different Than Those For Men: What Are The Implications |
|
Presenter(s):Tara M. Mastracci, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:05 PM - 5:10 PM | Progress And Improvements In F/B/EVAR Decrease Complications And Improve Results |
|
Presenter(s):Federico E. Parodi, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:10 PM - 5:15 PM | New Developments In The Treatment And Results Of Aorto-Enteric Fistulas: From The Low Frequency Vascular Disease Consortium |
|
Presenter(s):Peter F. Lawrence, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:15 PM - 5:20 PM | Technical Tips For AAA Sac Branch Embolization During EVAR: When And How To Do It And What Is Its Value |
|
Presenter(s):Eric Allaire, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:20 PM - 5:25 PM | Panel Discussion |
| CAROTID RELATED TOPICS | |
| 5:25 PM - 5:30 PM | Mini-Incision CEA Is Safer, Cheaper And More Effective Than TCAR: How To Do It In Most Patients Needing Invasive Treatment |
|
Presenter(s):Enrico Ascher, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:30 PM - 5:35 PM | Update On Current Outcomes Of CEA And CAS In Women: What Are The Implications |
|
Presenter(s):Caron B. Rockman, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:35 PM - 5:40 PM | DEBATE: Screening For Carotid Disease Will Prevent Strokes And Should Be Expanded: To Whom |
|
Presenter(s):George S. Lavenson, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:40 PM - 5:45 PM | DEBATE: Not So: Screening More Widely For Carotid Disease Will Cause More Harm Than Benefit: Why |
|
Presenter(s):Anne L. Abbott, MD, PhD, FRACP Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:45 PM - 5:50 PM | Safety Of CEA And CAS In Patients With A History Of Coronary Artery Disease: From The 4 RCTs |
|
Presenter(s):Gert J. de Borst, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:50 PM - 5:55 PM | Technical Tips And Indications For Eversion CEA: When Is It Best And When Not |
|
Presenter(s):Timothy M. Sullivan, MD Location: Trianon Ballroom, 3rd Floor |
|
| View Slides in PDF | |
| 5:55 PM - 6:00 PM | Panel Discussion End of Program F |
| END OF SESSION 46 | |